confusing the general pediatricians. Thus, there is a search to find a formula to guess GFR value correctly using endogen indicators such as serum urea, creatinine, and cystatin C (CysC) in children. 4 Our aim in this study was to assess correlations between eGFR equations based on Scr, CysC, CysC-Scr, and creatinine clearance.
We ultimately wanted to determine the most reliable equation for children in measuring eGFR.
| ME THODS
This study was conducted between September 2016 and March 2017 at Ege University Children Hospital. Two hundred and thirty-eight children were included in the study. Ethical approval was taken from the Ege University Medical Faculty Board of Ethics for Clinical Studies.
Parents of all the participants gave verbal consent to join the study.
Inclusion criteria were children aged 2-18 years followed up at the nephrology outpatients, who came to their control visits with an appropriately collected 24-urine sample.
Children under 2 years of age; receiving glucocorticoids, cimetidine, or trimethoprim therapy within the previous 3 months; diabetic patients with ketoacidosis, thyroid dysfunction (hypo-or hyperthyroidism), with known leukemia or other types of cancer, severe malnutrition; acute kidney injury; general oedema; severe heart failure receiving hemodialysis or peritoneal dialysis; absence of limbs; having high C-reactive protein levels; and noncooperative patients (not complying with urine collection instructions) were excluded. To check for exclusion criteria, we measured from all patients fasting blood sugar, urinary ketone levels (only in diabetic patients), serum C-reactive protein, serum-free T4, and serum TSH levels.
Weight and height were measured from all participants. The body mass index (BMI) was calculated, and participants with a BMI of above 95 percentile were excluded as well. Seventy applicants met some exclusion criteria (Figure 1 ). Serum urea, creatinine, and cystatin C were measured in all children. The blood urea nitrogen (BUN) was also calculated using urea values (BUN = urea × 0.467). Simultaneously, the 24-hour urine volume was measured, followed by a calculation of the 24-hour urinary creatinine clearance as creatinine excretion per kilogram of body weight (total urinary creatinine/patient's weight). If the 24-hour urinary creatinine was at least 20 mg/kg/24 hours, the amount of urine collected was regarded as adequate. 5 The 24-hour urinary creatinine clearance (CrCl24) was calculated by the following formula: Ucr = Urinary creatinine, Scr = Serum creatinine Urine creatinine, serum creatinine, and serum urea measurement were performed by Synchron (Beckman Coulter) brand urea and creatinine kits, which were photometrically measured on a DxC800 model, Beckman Coulter brand autoanalyzer using the Jaffé method.
CysC was measured by the "Particle Enhanced Nephelometric
Immunoassay" (PENIA) method.
| Estimation of GFR equations
In this study, we calculated eGFR by the following serum creatininebased equations: Original Schwartz, 6 Bedside Schwartz (eGFR), 7 Counahan-Barratt, 8 British Columbia Children's Hospital (BCCH 1 and 2), 9 Gao, 10 and the Lund-Malmö.
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We also calculated eGFR using the following cystatin C-based equations: Hoek, 12 Bricon et al, 13 Larsson et al, 14 Rule et al, 15 Filler and Lepage, 16 Zappitelli et al, 17 and the CKiD-eGFR-cysC. 18 CKiD-eGFR-Scr-cysC was calculated using the CKiD study formula utilizing cystatin C and serum creatinine. 18 For the CKiD-eGFRScr-cysC equation, the enzymatic serum creatinine measurements were converted into isotope dilution mass spectroscopy (IDMS) standard values. 7 The formulas for the different equations are given in Table 1 .
We accepted CrCl 24 as a gold-standard test. CysC-based eGFR Equations and Scr-based eGFR equations were evaluated for their own correlation. GFR <90 mL/min/1.73 m 2 was regarded as abnormal kidney function. We identified the specificity and sensitivity of each equation in differentiating abnormal kidney functions.
| Statistical analysis
As the distribution of all variables was skewed, results were presented as mean ± standard deviation (SD) and as median and min- 
| RE SULTS
The clinical characteristics of the participants (n = 238) are shown in 
| Performance of the Creatinine-based eGFR Equations
Creatinine-based estimations of eGFR were presented as median (min-max). The patient counts and percentages were displayed according to GFR at a cutoff level of 90 mL/min/1.73 m 2 . Sensitivity and specificity were evaluated by each equation (Table 3 ). 
| D ISCUSS I ON
New eGFR equations have been improved for better GFR guess and practical usage. The accuracy of these equations is essential.
In clinical practice, eGFR calculated by these equations is used to regulate the dosage of nephrotoxic drugs and to determine chronic renal disease. The eGFR value is associated with the performance of the eGFR equation. 19 The most common Scr-based eGFR equations used in practice depend on anthropometric measurements.
Of these, the Schwartz equation is usually used to assess eGFR value. It is believed that Scr-based eGFR will not be reliable, and its usage in children with conditions which affect muscle mass (such as malnutrition, obesity, anorexia, cachexia, and loss of extremities) is not suitable. 20 Because of this, eGFR equations which use cystatin C (cysC) have been developed. 21 Compared with Scr-based eGFR, cysC-based eGFR equations have been found to be more reliable in several adult clinical studies. 22 A study conducted among children has demonstrated that prediction equations based on CysC levels are likely to provide more accurate estimates of GFR than SCr-based equations. 17 Another study carried out in renal transplant patients has revealed a better performance of cystatin C-based formula compared with the traditional creatinine-based equations in predicting GFR among patients with kidney transplantation. 23 However, as the cost of cysC measurement is approximately eight times more than serum creatinine, it is not recommended for clinical practice. 24 In this study, we determined the value of cysC-based eGFR equations in children. All of the cysC-based eGFR equations were correlated with each other; neither one was superior. However, the CKiD-cysC and CKiD-Scr-cysC equations were more valuable concerning the areas under the ROC as well as sensitivity and specificity values.
In a study by Bacchetta et al, cysC-based eGFR equations
were not shown to be superior to Scr-based eGFR equations in F I G U R E 4 Roc curve analysis for all eGFR equations determining eGFR. 4 In another study, they found that the CKiDcysC and CKiD-Scr-cysC equations were better than the Scr-based eGFR equation. 25 In our research, cysC-based eGFR equations had no major superiority in evaluating eGFR compared to the Scr-based 28 In practice, it is often im- 
| CON CLUS IONS
The "Chronic Kidney Disease in Children" (CKiD) Scr-cysC and Scr-cysC formula were identified as the most valuable ones. However, in our study, Scr-based formulas were not much superior to the cysC-based formulas in predicting eGFR in children. It has been found that the use of Scr-based eGFR formulas in estimating GFR in children is more reliable. We think Bedside Schwartz is a good formula to provide ease of use in the daily practice, as the constant k in the formula is the same for all age groups. The use of eGFR formulas in identifying chronic kidney disease has been shown to be more reliable for the formulas using cysC and Scr in combination. We think that the CKiD-cysC and the CKiDScr-cysC equations are more effective eGFR equations in the early recognition of chronic kidney disease. Future research will probably be concerned with the identification of new formulas, novel exogenous agents, and new endogenous markers that are used to determine GFR in children.
The most important limitation of this study is having used the GFR as gold standard. We also could categorize GFR values as above 90, 60-90, and <60 mL/min/1.73 m 2 , which could provide extra valuable information concerning sensitivity and specificity thresholds. The heterogeneity of the study population with variability in the age, height, and weight, as well as the relatively low sample size, can be listed as additional limitations.
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